Ho Carole

EDGAR CIK 0001724605

Denali Therapeutics Inc. - DNLI

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
Chief Medical Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($51,684)
-3,743 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/13/2025
10b5-1
08/14/2025
Sell
-806 @ $14.64
 ($11,800) 216,585 (-0.37%) Direct
08/12/2025
08/14/2025
Sell
-2,937 @ $13.58
 ($39,884) 217,391 (-1.33%) Direct